Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types

DOI: 10.1080/2162402X.2018.1466018

Keywords: histone deacetylase, HDAC, avelumab, ADCC, solid carcinoma, vorinostat, entinostat, NK cell function, checkpoint inhibitor, PD-L1

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text